zileuton has been researched along with bay x 1005 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brooks, CD; Summers, JB | 1 |
| Bell, RL; Bhatia, P; Bouska, JB; Brooks, CD; Carter, GW; Gane, T; Gunn, DE; Harris, RR; Hulkower, KI; Kolasa, T; Malo, PE; Stewart, AO; Woods, KW | 1 |
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Carpenter, TG; Cuthbert, NJ; Fitzgerald, MF; Francis, HP; Gardiner, PJ; Mohrs, K; Müller-Peddinghaus, R; Newton, BB; Patel, UP; Thompson, AM | 1 |
| Medvedeff, ED; Nickerson-Nutter, CL | 1 |
| Dahlén, SE; Larsson, L; Sydbom, A | 1 |
| Badr, KF; Montero, A; Munger, KA; Valdivielso, JM | 1 |
1 review(s) available for zileuton and bay x 1005
| Article | Year |
|---|---|
Modulators of leukotriene biosynthesis and receptor activation.
Topics: 5-Lipoxygenase-Activating Proteins; Animals; Carrier Proteins; Forecasting; Humans; Leukotriene B4; Leukotrienes; Lipoxygenase Inhibitors; Membrane Proteins; Molecular Structure; Receptors, Leukotriene | 1996 |
6 other study(ies) available for zileuton and bay x 1005
| Article | Year |
|---|---|
Heteroarylmethoxyphenylalkoxyiminoalkylcarboxylic acids as leukotriene biosynthesis inhibitors.
Topics: Acrylic Resins; Anaphylaxis; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Ascitic Fluid; Granuloma; Humans; In Vitro Techniques; Leukotriene B4; Male; Mice; Neutrophils; Pleuropneumonia; Pneumonia; Quinolines; Rats; Stereoisomerism; Structure-Activity Relationship | 2000 |
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Inhibition of antigen-induced contraction of guinea-pig airways by a leukotriene synthesis inhibitor, BAY x1005.
Topics: 5-Lipoxygenase-Activating Proteins; Administration, Oral; Animals; Benzoquinones; Bronchoconstriction; Carrier Proteins; Guinea Pigs; Hydroxyurea; In Vitro Techniques; Indoles; Injections, Intravenous; Leukotriene Antagonists; Lipoxygenase Inhibitors; Male; Membrane Proteins; Ovalbumin; Pyrans; Quinolines; Quinolones; Trachea | 1994 |
The effect of leukotriene synthesis inhibitors in models of acute and chronic inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Chronic Disease; Disease Models, Animal; Drug Combinations; Exudates and Transudates; Female; Hydroxyurea; Inflammation; Leukotriene B4; Lipoxygenase; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Naproxen; Prostaglandin-Endoperoxide Synthases; Quinolines; Time Factors; Zymosan | 1996 |
Selective effects of antileukotrienes on leukotriene and histamine release in human dispersed lung cells.
Topics: Histamine H1 Antagonists; Histamine Release; Humans; Hydroxyurea; Indazoles; Leukotriene Antagonists; Leukotrienes; Lipoxygenase Inhibitors; Lung; Lung Neoplasms; Pyrilamine; Quinolines | 1999 |
Inhibition of 5-LO activating protein (FLAP) activity decreases proteinuria in streptozotocin (STZ)-induced diabetic rats.
Topics: 5-Lipoxygenase-Activating Proteins; Animals; Blood Glucose; Blood Urea Nitrogen; Carrier Proteins; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diuresis; Hydroxyurea; Lipoxygenase Inhibitors; Male; Membrane Proteins; Proteinuria; Quinolines; Rats; Rats, Sprague-Dawley | 2002 |